tirzepatide and bipolar disorder Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in disorder: a narrative review of preclinical clinical evidence Can tirzepatide cause anxiety? What

Semaglutides cardiovascular benefit data (the SELECT trial, 2023) remains a distinct advantage for high-risk patients, and this consideration may guide some providers to recommend semaglutide even for patients currently on tirzepatide

While the meds handle the biology, we still need to address the underlying emotional triggers and change of eating habits to ensure long-term recovery after stopping the medication

NICE guidance (NG207) acknowledges that weight maintenance after initial loss represents a clinically meaningful outcome, as preventing weight regain offers substantial health benefits including improved cardiovascular risk profile and glycaemic control

Approximately 3 million Americans have pacemakers or other cardiac implants, and many struggle with weight management alongside their heart conditions

As a result, manufacturer savings cards could be a viable option for those with diabetes and commercial insurance, offering potential cost relief

CLINICAL OUTCOMES What to expect from a semaglutide protocol Based on STEP-1 and STEP-3 evidence and on what our Houston cohort actually sees